Discover Biotech Webinar Pharma FDA & EMA ONCOLife Contact

Cancer Related News

FDA-Cleared Utepreva Device Aims to Improve Early Endometrial Cancer Detection
CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing
Non-Surgical Skin Cancer Treatment Achieves 99% Cure Rate
Location of T Cells Could Revolutionize Immunotherapy Success in Lung Cancer

Most Popular

Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization

Improving Everolimus Safety in Oncology: Missed Opportunities in Risk Minimization

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

Targeting the ‘Don’t Eat Me’ Signal: The Future of Macrophage Checkpoint Inhibitors

FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults

FDA Approves Wegovy to Reduce Risk of Heart Problems in Obese Adults

A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH

A New Era in Liver Disease: FDA Approves First Medication 'Rezdiffra' for NASH

Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR

Zongertinib Gains FDA Accelerated Approval for HER2+ NSCLC with 75% ORR

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

Exploring the Transformative Power of AI in Drug Discovery: A report by S&P Global

NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment

NETTER-2 Trial: Lutathera Cuts Risk of Death by 72% in Neuroendocrine Tumor Treatment

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

EpCAM-Targeting ADC CX-2051 Shows Promising Efficacy in Advanced Colorectal Cancer

FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis

FDA Grants Accelerated Approval to Semaglutide for MASH with Liver Fibrosis

Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases

Bayer Poised for Landmark Year with Blockbuster Treatment Advances Across Key Diseases

Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B

Transformative One-Time Gene Therapy: FDA Approves Pfizer's BEQVEZ, for Hemophilia B

NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer

NEJM Study Confirms Low-Dose Aspirin Halves Recurrence in Colorectal Cancer

FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma

FDA Approves Groundbreaking CAR T Cell Therapy, Abecma, for Multiple Myeloma

New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages

New Horizon in Food Allergy Treatment: FDA Approves Xolair for All Ages

FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma

FDA Approves Carvykti as Targeted CAR-T Cell Therapy for Multiple Myeloma